The biggest proton therapy stories of 2018

The biggest proton therapy stories of 2018

by John R. Fischer, Senior Reporter | January 02, 2019
Rad Oncology Proton Therapy
Model of ProBeam 360
Though slow to adopt, proton therapy is making waves in the progression of cancer treatment as more centers and new technologies dedicated to the practice enter the market in the U.S. and abroad, raising the bar for what is or will be possible for cancer care in the next few years.

Here is a list of the top five proton therapy current events from 2018.

At ASTRO, Varian introduces smaller footprint proton system, talks ‘flash’ therapy

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs

Cutting irradiation time by 75 percent became possible with the introduction of Varian’s ProBeam 360°.

Debuting this past fall at ASTRO, the single-room PT system offers a 30 percent lower footprint than its predecessor, reducing vault construction costs by approximately 25 percent. Even more important is the access it is expected to provide to flash therapy, a treatment that applies high doses at ultra-high speeds in less than a second, and can be delivered in one to three sessions. The subject is the main focus of Varian’s new research initiative, the FlashForward Consortium.

“The real mission of the consortium is to help us advance that therapy into clinical use,” Bill Hansen, strategic initiatives director for Varian, told HCB News at the annual meeting. “They’ll help with the preclinical work that we’re doing now, which we will not only continue but expand in terms of the various preclinical tests we’re doing with animals. We’ll prepare for the first clinical trials in humans, and the consortium will help us define what those clinical trials should be. We’ll probably pick one or two disease sites where we’ll start those trials.”

You Must Be Logged In To Post A Comment